Ozanimod

ATC L04AE02 · 8 markets · 20 records

Ozanimod 8 markets · 20 records Forms

AU 5 records · 6 strengths

  • 0.92 mgcapsuleZEPOSIA also in TW·CA·ES +1
  • 0.23 mgcapsuleZEPOSIA also in TW·CA·ES
  • 1 mgcapsuleZEPOSIA ozanimod 920 microgram capsules blister pack unknown
  • 0.5 mgcapsuleZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack unknown
  • 0.25 mgcapsuleZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack unknown

Records without a stated strength · 1 ZEPOSIA

GB 4 records · 1 strengths

    Records without a stated strength · 1 ZEPOSIA、Zeposia 0.23mg/0.46mg capsules treatment initiation pack

    TW 3 records · 3 strengths

    • 0.92 mgcapsuleZEPOSIA捷保舒膠囊0.92毫克 also in AU·CA·ES +1
    • 0.23 mgcapsuleZEPOSIA捷保舒膠囊0.23毫克 also in AU·CA·ES
    • 0.46 mgcapsuleZEPOSIA捷保舒膠囊0.46毫克 also in CA

    CA 2 records · 3 strengths

    ES 2 records · 2 strengths

    HK 2 records · 1 strengths

      Records without a stated strength · 1 ZEPOSIA、ZEPOSIA CAPSULES 0.23MG AND 0.46MG (TREATMENT INITIATION PACK)

      US 1 records · 1 strengths

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 ZEPOSIA

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.